US to phase out epinephrine inhalers by 2011
This article was originally published in Scrip
Executive Summary
Manufacturers of albuterol (salbutamol) metered-dose inhalers will have an extra year to ramp up production so that sufficient supplies are available when over-the-counter epinephrine (adrenaline) inhalers are removed from the US market.